{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T07:00:11Z","timestamp":1792652411081,"version":"4.5.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,4]],"date-time":"2018-02-04T00:00:00Z","timestamp":1517702400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.xphs.2018.01.027","type":"journal-article","created":{"date-parts":[[2018,2,6]],"date-time":"2018-02-06T07:31:15Z","timestamp":1517902275000},"page":"1540-1551","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Development of Stabilizing Formulations of a Trivalent Inactivated Poliovirus Vaccine in a Dried State for Delivery in the Nanopatch\u2122 Microprojection Array"],"prefix":"10.1016","volume":"107","author":[{"given":"Ying","family":"Wan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Hickey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Bird","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katey","family":"Witham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Fahey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angus","family":"Forster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sangeeta B.","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David B.","family":"Volkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"35","key":"10.1016\/j.xphs.2018.01.027_bib1","doi-asserted-by":"crossref","first-page":"934","DOI":"10.15585\/mmwr.mm6535a3","article-title":"Cessation of trivalent oral poliovirus vaccine and introduction of inactivated poliovirus vaccine\u2013worldwide, 2016","volume":"65","author":"Hampton","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.xphs.2018.01.027_bib2","doi-asserted-by":"crossref","first-page":"22094","DOI":"10.1038\/srep22094","article-title":"Inactivated poliovirus type 2 vaccine delivered to rat skin via high density microprojection array elicits potent neutralising antibody responses","volume":"6","author":"Muller","year":"2016","journal-title":"Sci Rep"},{"issue":"7","key":"10.1016\/j.xphs.2018.01.027_bib3","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1586\/erv.09.49","article-title":"Future of polio vaccines","volume":"8","author":"Ehrenfeld","year":"2009","journal-title":"Expert Rev Vaccines"},{"issue":"5","key":"10.1016\/j.xphs.2018.01.027_bib4","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1586\/erv.09.20","article-title":"Opportunities and challenges of developing thermostable vaccines","volume":"8","author":"Chen","year":"2009","journal-title":"Expert Rev Vaccines"},{"issue":"41","key":"10.1016\/j.xphs.2018.01.027_bib5","doi-asserted-by":"crossref","first-page":"7188","DOI":"10.1016\/j.vaccine.2011.05.079","article-title":"Inactivated polio vaccine development for technology transfer using attenuated Sabin poliovirus strains to shift from Salk-IPV to Sabin-IPV","volume":"29","author":"Bakker","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.xphs.2018.01.027_bib6","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.biologicals.2017.05.001","article-title":"Scientific consultation on the safety and containment of new poliovirus strains for vaccine production, clinical\/regulatory testing and research. Report of a meeting held at NIBSC, Potters Bar, Hertfordshire, UK, 6\/7th July 2016","volume":"48","author":"Minor","year":"2017","journal-title":"Biologicals"},{"issue":"18","key":"10.1016\/j.xphs.2018.01.027_bib7","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1016\/j.vaccine.2011.02.085","article-title":"Characterization and standardization of Sabin based inactivated polio vaccine: proposal for a new antigen unit for inactivated polio vaccines","volume":"29","author":"Westdijk","year":"2011","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.xphs.2018.01.027_bib8","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1007\/s11095-014-1359-6","article-title":"Development of thermostable lyophilized inactivated polio vaccine","volume":"31","author":"Kraan","year":"2014","journal-title":"Pharm Res"},{"key":"10.1016\/j.xphs.2018.01.027_bib9","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jconrel.2016.05.012","article-title":"Thermostabilization of inactivated polio vaccine in PLGA-based microspheres for pulsatile release","volume":"233","author":"Tzeng","year":"2016","journal-title":"J\u00a0Control Release"},{"issue":"17","key":"10.1016\/j.xphs.2018.01.027_bib10","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1016\/j.vaccine.2015.03.011","article-title":"Alternative delivery of a thermostable inactivated polio vaccine","volume":"33","author":"Kraan","year":"2015","journal-title":"Vaccine"},{"issue":"37","key":"10.1016\/j.xphs.2018.01.027_bib11","doi-asserted-by":"crossref","first-page":"4683","DOI":"10.1016\/j.vaccine.2015.01.089","article-title":"Inactivated polio vaccination using a microneedle patch is immunogenic in the rhesus macaque","volume":"33","author":"Edens","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.xphs.2018.01.027_bib12","first-page":"369","article-title":"Microneedle-based vaccines","volume":"333","author":"Prausnitz","year":"2009","journal-title":"Curr Top Microbiol Immunol"},{"issue":"2","key":"10.1016\/j.xphs.2018.01.027_bib13","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.jconrel.2012.01.042","article-title":"Microneedle technologies for (trans)dermal drug and vaccine delivery","volume":"161","author":"van der Maaden","year":"2012","journal-title":"J\u00a0Control Release"},{"issue":"14","key":"10.1016\/j.xphs.2018.01.027_bib14","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/j.addr.2012.04.005","article-title":"Microneedles for drug and vaccine delivery","volume":"64","author":"Kim","year":"2012","journal-title":"Adv Drug Deliv Rev"},{"issue":"34","key":"10.1016\/j.xphs.2018.01.027_bib15","doi-asserted-by":"crossref","first-page":"3403","DOI":"10.1016\/j.vaccine.2012.09.062","article-title":"Measles vaccination using a microneedle patch","volume":"31","author":"Edens","year":"2013","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.xphs.2018.01.027_bib16","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1007\/s11095-017-2223-2","article-title":"Dissolving microneedle patches for dermal vaccination","volume":"34","author":"Leone","year":"2017","journal-title":"Pharm Res"},{"key":"10.1016\/j.xphs.2018.01.027_bib17","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jconrel.2016.06.045","article-title":"Influenza nucleoprotein DNA vaccination by a skin targeted, dry coated, densely packed microprojection array (Nanopatch) induces potent antibody and CD8(+) T cell responses","volume":"237","author":"Fernando","year":"2016","journal-title":"J\u00a0Control Release"},{"issue":"7","key":"10.1016\/j.xphs.2018.01.027_bib18","doi-asserted-by":"crossref","first-page":"e67888","DOI":"10.1371\/journal.pone.0067888","article-title":"Dry-coated live viral vector vaccines delivered by nanopatch microprojections retain long-term thermostability and induce transgene-specific T cell responses in mice","volume":"8","author":"Pearson","year":"2013","journal-title":"PLoS One"},{"issue":"16","key":"10.1016\/j.xphs.2018.01.027_bib19","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1002\/smll.201000331","article-title":"Nanopatch-targeted skin vaccination against West Nile Virus and Chikungunya virus in mice","volume":"6","author":"Prow","year":"2010","journal-title":"Small"},{"issue":"48","key":"10.1016\/j.xphs.2018.01.027_bib20","doi-asserted-by":"crossref","first-page":"6675","DOI":"10.1016\/j.vaccine.2015.10.081","article-title":"Functional anti-polysaccharide IgG titres induced by unadjuvanted pneumococcal-conjugate vaccine when delivered by microprojection-based skin patch","volume":"33","author":"Pearson","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.xphs.2018.01.027_bib21","doi-asserted-by":"crossref","first-page":"27217","DOI":"10.1038\/srep27217","article-title":"The changing shape of vaccination: improving immune responses through geometrical variations of a microdevice for immunization","volume":"6","author":"Crichton","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.xphs.2018.01.027_bib22","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.actbio.2016.02.039","article-title":"Characterising the material properties at the interface between skin and a skin vaccination microprojection device","volume":"36","author":"Crichton","year":"2016","journal-title":"Acta Biomater"},{"key":"10.1016\/j.xphs.2018.01.027_bib23","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jconrel.2014.09.028","article-title":"Microprojection arrays to immunise at mucosal surfaces","volume":"196","author":"McNeilly","year":"2014","journal-title":"J\u00a0Control Release"},{"issue":"3","key":"10.1016\/j.xphs.2018.01.027_bib24","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.jconrel.2011.02.026","article-title":"Improving the reach of vaccines to low-resource regions, with a needle-free vaccine delivery device and long-term thermostabilization","volume":"152","author":"Chen","year":"2011","journal-title":"J\u00a0Control Release"},{"issue":"16","key":"10.1016\/j.xphs.2018.01.027_bib25","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1002\/smll.201000326","article-title":"Targeted, needle-free vaccinations in skin using multilayered, densely-packed dissolving microprojection arrays","volume":"6","author":"Raphael","year":"2010","journal-title":"Small"},{"key":"10.1016\/j.xphs.2018.01.027_bib26","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jconrel.2016.01.027","article-title":"Formulations for microprojection\/microneedle vaccine delivery: structure, strength and release profiles","volume":"225","author":"Raphael","year":"2016","journal-title":"J\u00a0Control Release"},{"issue":"8","key":"10.1016\/j.xphs.2018.01.027_bib27","doi-asserted-by":"crossref","first-page":"3490","DOI":"10.1039\/c2ra20153d","article-title":"High density and high aspect ratio solid micro-nanoprojection arrays for targeted skin vaccine delivery and specific antibody extraction","volume":"2","author":"Jenkins","year":"2012","journal-title":"RSC Adv"},{"issue":"16","key":"10.1016\/j.xphs.2018.01.027_bib28","doi-asserted-by":"crossref","first-page":"4562","DOI":"10.1016\/j.biomaterials.2010.02.022","article-title":"The effect of strain rate on the precision of penetration of short densely-packed microprojection array patches coated with vaccine","volume":"31","author":"Crichton","year":"2010","journal-title":"Biomaterials"},{"issue":"9","key":"10.1016\/j.xphs.2018.01.027_bib29","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1038\/jid.2014.174","article-title":"Co-localization of cell death with antigen deposition in skin enhances vaccine immunogenicity","volume":"134","author":"Depelsenaire","year":"2014","journal-title":"J\u00a0Invest Dermatol"},{"issue":"1","key":"10.1016\/j.xphs.2018.01.027_bib30","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/jps.23801","article-title":"Preformulation study of highly purified inactivated polio vaccine, serotype 3","volume":"103","author":"Qi","year":"2014","journal-title":"J\u00a0Pharm Sci"},{"key":"10.1016\/j.xphs.2018.01.027_bib31","series-title":"Inactive ingredient search for approved drug products","year":"2017"},{"issue":"13","key":"10.1016\/j.xphs.2018.01.027_bib32","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.addr.2011.07.006","article-title":"Protein-excipient interactions: mechanisms and biophysical characterization applied to protein formulation development","volume":"63","author":"Kamerzell","year":"2011","journal-title":"Adv Drug Deliv Rev"},{"issue":"12","key":"10.1016\/j.xphs.2018.01.027_bib33","first-page":"905","article-title":"Structural background of cyclodextrin\u2013protein interactions. Protein Engineering","volume":"16","author":"Aachmann","year":"2003","journal-title":"Des Selection"},{"issue":"13","key":"10.1016\/j.xphs.2018.01.027_bib34","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.addr.2011.08.003","article-title":"Protein stabilization by cyclodextrins in the liquid and dried state","volume":"63","author":"Serno","year":"2011","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.xphs.2018.01.027_bib35","unstructured":"Chacornac I, Francon A, Vacus P. Vaccine composition comprising ipv and cyclodextrins. 2016, Google Patents."},{"issue":"10","key":"10.1016\/j.xphs.2018.01.027_bib36","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1016\/j.vaccine.2017.01.070","article-title":"Glutathione is a highly efficient thermostabilizer of poliovirus Sabin strains","volume":"35","author":"Abdelnabi","year":"2017","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.xphs.2018.01.027_bib37","doi-asserted-by":"crossref","first-page":"e1004039","DOI":"10.1371\/journal.ppat.1004039","article-title":"Binding of glutathione to enterovirus capsids is essential for virion morphogenesis","volume":"10","author":"Thibaut","year":"2014","journal-title":"PLoS Pathog"},{"issue":"4","key":"10.1016\/j.xphs.2018.01.027_bib38","doi-asserted-by":"crossref","first-page":"e1004052","DOI":"10.1371\/journal.ppat.1004052","article-title":"An interaction between glutathione and the capsid is required for the morphogenesis of C-cluster enteroviruses","volume":"10","author":"Ma","year":"2014","journal-title":"PLoS Pathog"},{"issue":"5","key":"10.1016\/j.xphs.2018.01.027_bib39","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.biologicals.2014.05.007","article-title":"Vaccine instability in the cold chain: mechanisms, analysis and formulation strategies","volume":"42","author":"Kumru","year":"2014","journal-title":"Biologicals"},{"issue":"6","key":"10.1016\/j.xphs.2018.01.027_bib40","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.biologicals.2009.08.009","article-title":"Vaccine stability study design and analysis to support product licensure","volume":"37","author":"Schofield","year":"2009","journal-title":"Biologicals"},{"issue":"1","key":"10.1016\/j.xphs.2018.01.027_bib41","doi-asserted-by":"crossref","first-page":"12644","DOI":"10.1038\/s41598-017-13011-0","article-title":"High-density microprojection array delivery to rat skin of low doses of trivalent inactivated poliovirus vaccine elicits potent neutralising antibody responses","volume":"7","author":"Muller","year":"2017","journal-title":"Sci Rep"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354918300716?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354918300716?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,7]],"date-time":"2019-06-07T14:29:23Z","timestamp":1559917763000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354918300716"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":41,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S0022354918300716"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2018.01.027","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of Stabilizing Formulations of a Trivalent Inactivated Poliovirus Vaccine in a Dried State for Delivery in the Nanopatch\u2122 Microprojection Array","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2018.01.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Inc. on behalf of the American Pharmacists Association\u00ae.","name":"copyright","label":"Copyright"}]}}